Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.63 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.41 |
| ▸ | CNR1 | P21554 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4057810 | 0.85 | KDM4E (0.50) | KDM4EMAPTCYP2D6L3MBTL1KMT2A | |
| Trifluoromethanesulfonic Acid SCHEMBL28182343 | 0.85 | KDM4E (0.51) | KDM4EMAPTCYP2D6L3MBTL1KMT2A | |
| Hydrochloric Acid SCHEMBL29054526 | 0.80 | KDM4E (0.55) | KDM4EMAPTCYP2D6L3MBTL1KMT2A | |
| Bromide SCHEMBL29054561 | 0.80 | KDM4E (0.55) | KDM4EMAPTCYP2D6L3MBTL1KMT2A | |
| SCHEMBL3401057 | 0.79 | KDM4E (0.67) | KDM4EMAPTCYP2D6L3MBTL1KMT2A | |
| SCHEMBL28215659 | 0.78 | KDM4E (0.56) | KDM4EMAPTCYP2D6L3MBTL1KMT2A | |
| SCHEMBL5299480 | 0.77 | TLR8 (0.48) | KDM4EKMT2AMEN1 | |
| SCHEMBL950298 | 0.77 | KDM4E (0.65) | KDM4EMAPTCYP2D6L3MBTL1KMT2A | |
| Hydrochloric Acid SCHEMBL29054527 | 0.77 | KDM4E (0.65) | KDM4EMAPTCYP2D6L3MBTL1KMT2A | |
| SCHEMBL30824582 | 0.77 | KDM4E (0.65) | KDM4EMAPTCYP2D6L3MBTL1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 102 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1984438-B2 | ANTISTATIC POLYURETHANE | BASF SE (DE) | 2016-05-18 | — | — | EP | claimed |
| US-20150057388-A1 | ANTISTATIC POLYURETHANE | BASF SE (DE) | 2015-02-26 | — | — | US | claimed |
| EP-1812382-B1 | METHOD FOR PRODUCING POLYISOCYANATES | BASF SE (DE) | 2013-01-23 | — | — | EP | claimed |
| JP-4794561-B2 | — | — | 2011-10-19 | — | — | JP | claimed |
| EP-1984438-B1 | ANTISTATIC POLYURETHANE | BASF SE (DE) | 2010-03-31 | — | — | EP | claimed |
| US-7659430-B2 | Method for separating hydrogen chloride and phosgene | BASF AKTIENGESELLSCHAFT (DE) | 2010-02-09 | — | — | US | claimed |
| US-20090300946-A1 | ANTISTATIC POLYURETHANE | BASF SE (DE) | 2009-12-10 | — | — | US | claimed |
| EP-1789160-B1 | METHOD FOR SEPARATING HYDROGEN CHLORIDE AND PHOSGENE | BASF SE (DE) | 2009-11-18 | — | — | EP | claimed |
| US-20090112017-A1 | METHOD FOR PRODUCING POLYISOCYANATES | BASF AKTIENGESSELLSCHAFT (DE) | 2009-04-30 | — | — | US | claimed |
| CN-101410444-A | Antistatic polyurethane | BASF SE (DE) | 2009-04-15 | — | — | CN | claimed |
| CN-101056848-A | Process for preparing polyisocyanates | BASF AG (DE) | 2007-10-17 | — | — | CN | claimed |
| WO-2007090755-A1 | ANTISTATIC POLYURETHANE | BASF AKTIENGESELLSCHAFT (DE) | 2007-08-16 | — | — | WO | claimed |
| EP-1812382-A1 | METHOD FOR PRODUCING POLYISOCYANATES | BASF AKTIENGESELLSCHAFT (DE) | 2007-08-01 | — | — | EP | claimed |
| EP-1805206-A2 | ELECTROCHEMICAL DEBLOCKING USING A HYDRAZINE DERIVATIVE | Combimatrix Corporation (US) | 2007-07-11 | — | — | EP | claimed |
| EP-1789160-A1 | METHOD FOR SEPARATING HYDROGEN CHLORIDE AND PHOSGENE | BASF AKTIENGESELLSCHAFT (DE) | 2007-05-30 | — | — | EP | claimed |
| WO-2007006418-A1 | IONIC-LIQUID-CONTAINING PRODUCTS FOR DYEING AND/OR BRIGHTENING KERATIN FIBRES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-01-18 | — | — | WO | claimed |
| WO-2006131234-A1 | COSMETIC COMPOSITIONS COMPRISING IONIC LIQUIDS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2006-12-14 | — | — | WO | claimed |
| WO-2006048171-A1 | METHOD FOR PRODUCING POLYISOCYANATES | BASF AKTIENGESELLSCHAFT (DE) | 2006-05-11 | — | — | WO | claimed |
| WO-2006029788-A1 | METHOD FOR SEPARATING HYDROGEN CHLORIDE AND PHOSGENE | BASF AKTIENGESELLSCHAFT (DE) | 2006-03-23 | — | — | WO | claimed |
| WO-2006031814-A2 | ELECTROCHEMICAL DEBLOCKING USING A HYDRAZINE DERIVATIVE | COMBIMATRIX CORPORATION (US) | 2006-03-23 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090112017-A1 | METHOD FOR PRODUCING POLYISOCYANATES | PGLS, INMT, PNMT | KDM4E 3386/4885MAPT 1739/4885CYP2D6 2045/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.